![]() 2-CMDO structure
|
Common Name | 2-CMDO | ||
---|---|---|---|---|
CAS Number | 24140-98-5 | Molecular Weight | 442.89200 | |
Density | N/A | Boiling Point | 474.1ºC at 760mmHg | |
Molecular Formula | C23H23ClN2O5 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 240.5ºC |
Use of 2-CMDORMI-61140 is an orally active neuroleptics. RMI-61140 decreases spontaneous motility and muscle tone in mice. RMI-61140 increases barbit urate-induced sleep and causes eyelid ptosis. RMI-61140 can be used for schizophrenia research[1]. |
Name | 1-(3-chlorobenzo[b][1]benzoxepin-5-yl)-4-methylpiperazin-4-ium,(Z)-4-hydroxy-4-oxobut-2-enoate |
---|---|
Synonym | More Synonyms |
Description | RMI-61140 is an orally active neuroleptics. RMI-61140 decreases spontaneous motility and muscle tone in mice. RMI-61140 increases barbit urate-induced sleep and causes eyelid ptosis. RMI-61140 can be used for schizophrenia research[1]. |
---|---|
Related Catalog | |
References |
Boiling Point | 474.1ºC at 760mmHg |
---|---|
Molecular Formula | C23H23ClN2O5 |
Molecular Weight | 442.89200 |
Flash Point | 240.5ºC |
Exact Mass | 442.13000 |
PSA | 90.31000 |
LogP | 3.77880 |
Vapour Pressure | 3.72E-09mmHg at 25°C |
1-(3-chlorobenzo[b][1]benzoxepin-5-yl)-4-methylpiperazin-4-ium |
Piperazine,1-(8-chlorodibenz(b,f)oxepin-10-yl)-4-methyl-,(Z)-2-butenedioate (1:1) |
Piperazine,1-(8-chlorodibenz(b,f)oxepin-10-yl)-4-methyl-,maleate (1:1) |
N-(8-Chloro-dibenzo(b,f)oxepin-10-yl)-N'-methylpiperazine maleate |
Piperazine,1-(8-chloro-10-dibenzo(b,f)oxepinyl)-4-methyl-,maleate |
Rmi 61,140 |